<DOC>
	<DOCNO>NCT02391909</DOCNO>
	<brief_summary>This multicenter ( travel clinic ) , phase 4 observational prospective cohort study healthy adult male female traveler typhoid vaccination Vivotif recommend , per standard practice .</brief_summary>
	<brief_title>Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers</brief_title>
	<detailed_description>This multicenter ( travel clinic ) , phase 4 observational prospective cohort study healthy adult male female traveler typhoid vaccination Vivotif recommend , per standard practice . The study enroll 950 subject randomize ratio 1:1 two group , A B , 475 subject . Group A receive 6.9-10.0 x109 CFU/capsule Group B receive 4.0-6.8 x109 CFU/capsule , respectively . All subject receive four dos Vivotif . One dose per subject administer Days 1 , 3 , 5 7 . Investigators , subject personnel involve run study aware actual release titer associate distributed lot . Blinding maintain use commercial packaging include actual value release titer .</detailed_description>
	<mesh_term>Typhoid Fever</mesh_term>
	<criteria>1 . Subjects male female age â‰¥ 18 year time dose 2 . Subjects traveler attend traveler ' vaccination clinic 3 . Subjects eligible typhoid vaccination , accord standard practice 4 . Subjects expect able provide followup information 5 . Subjects expect travel departure date 21 day enrollment ( enhance followup ensure subject remain US AE collection period ) 6 . Subjects must sign write informed consent 1 . Subjects know hypersensitivity component vaccine enteric coat capsule 2 . Subjects deficient ability mount humoral cellmediated immune response due either congenital acquire immunodeficient state include treatment immunesuppressive antimitotic drug 3 . Subjects acute febrile illness 4 . Subjects acute gastrointestinal ( GI ) illness 5 . Subjects receive medication antibacterial activity ( include proguanil ) time enrollment 6 . Subjects contraindication determine site investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Vaccine</keyword>
</DOC>